Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood Advances|September 25, 2023
Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody-drug conjugateKarin Gustafsson, Catherine Rhee, Vanessa Frodermann, et al.
Chembiochem : a European Journal of Chemical Biology|November 1, 2013
Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitorEmilia C Calvaresi, Carlotta Granchi, Tiziano Tuccinardi, et al.
Molecular Pharmaceutics|April 11, 2012
Differential effects of procaspase-3 activating compounds in the induction of cancer cell deathDiana C West, Yan Qin, Quinn P Peterson, et al.
Molecular Therapy. Methods & Clinical Development|April 1, 2020
Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based ConditioningMeera A Srikanthan, Olivier Humbert, Kevin G Haworth, et al.
Nature Biotechnology|June 9, 2016
Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxinRahul Palchaudhuri, Borja Saez, Jonathan Hoggatt, et al.
Cell Reports|December 15, 2015
A Small Molecule that Induces Intrinsic Pathway Apoptosis with Unparalleled SpeedRahul Palchaudhuri, Michael J Lambrecht, Rachel C Botham, et al.
The Journal of Allergy and Clinical Immunology|May 11, 2020
Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiencyMaria Carmina Castiello, Marita Bosticardo, Nicolò Sacchetti, et al.
Nature Communications|February 8, 2019
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservationAgnieszka Czechowicz, Rahul Palchaudhuri, Amelia Scheck, et al.
Journal of Medicinal Chemistry|February 22, 2011
Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cellsCarlotta Granchi, Sarabindu Roy, Chiara Giacomelli, et al.
Science Translational Medicine|October 13, 2017
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1Giulia Schiroli, Samuele Ferrari, Anthony Conway, et al.
Pageof 3